Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb-Mar;20(2-3):73-76.
doi: 10.1080/17460751.2025.2480003. Epub 2025 Mar 26.

The future of ex vivo hematopoietic stem cell gene editing: what's next

Alessia Cavazza  1   2 , Giorgia Santilli  2
Affiliations

The future of ex vivo hematopoietic stem cell gene editing: what's next

Alessia Cavazza et al. Regen Med. 2025 Feb-Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

References

    1. Duncan CN, Bledsoe JR, Grzywacz B, et al. Hematologic cancer after gene therapy for cerebral adrenoleukodystrophy. N Engl J Med. 2024. Oct 10;391(14):1287–1301. - PMC - PubMed
    1. Pacesa M, Pelea O, Jinek M.. Past, present, and future of CRISPR genome editing technologies. Cell. 2024. Feb 29;187(5):1076–1100. - PubMed
    1. Frangoul H, Locatelli F, Sharma A, et al. Exagamglogene autotemcel for severe sickle cell disease. N Engl J Med. 2024. May 9;390(18):1649–1662. - PubMed
    1. Meng Q, Sun H, Liu J.. Precise somatic genome editing for treatment of inborn errors of immunity. Front Immunol. 2022;13:960348. - PMC - PubMed
    1. Rai R, Romito M, Rivers E, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich syndrome. Nat Commun. 2020. Aug 12;11(1):4034. - PMC - PubMed

LinkOut - more resources